Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2007-003073-97Phase 3Completed
Phase 3, randomised trial in plaque psoriasis and psoriasis comparing Adalimumab + calcipotriol/betamethasone with Adalimumab + topical vehicle (2 arms). Primary endpoint: PASI75 response at Week 16. Started Sep 2007; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2007-003073-97.